Introduction
============

According to the ([@B49]), 1.7 billion people (23%) of the world's population are estimated to have latent TB infection, indicating a risk of developing active TB during their lifetime ([@B49]). Approximately 10.4 million incidences of TB occurred worldwide, including 5 million (56%) men, 3.5 million (34%) women and 1 million (10%) among children ([@B47]). Due to an increase in the world's population, the health care units are continuously struggling to improve the standard and reduce the transmission and cost. Methods commonly used to diagnose TB include, GeneXpert assay, sputum-smear microscopy and chest radiography ([@B12]; [@B16]). However, diagnosis became more complicated when the infectious agent spread to other parts of the body -- this is referred to as extra pulmonary TB. All these diagnostic methods possess some limitations. Culture method is considered the gold standard for detection of the causative agent of TB, *Mycobacterium tuberculosis* (MTB) but it is time consuming in diagnosis and the chances of contamination are high ([@B10]; [@B35]; [@B4]). Some common issues reported from other diagnostics methods include performance issues, sputum samples from children (pediatric cases), live MTB, highly skilled medical staff for high throughput tools and high cost ([@B12]; [@B36]). Delay in diagnosis may lead to drug resistance, multidrug resistance (MDR), where an isolate shows resistance to two first line drugs, rifampicin and isoniazid, and extensive drug resistance (XDR) which include MDR and also show resistance to fluoroquinolones and at least one of the injectable drug ([@B42]).

In health sciences, wet lab tests can be time consuming and the chances of contamination could further lead the disease to an irreversible state. Although the Xpert MTB/RIF assay offers a fast diagnostic facility within 2 h, but due to low sensitivity in some sample types and cost may lead to more serious state of disease ([@B36]).

In the last few decades, the researchers have collected an extensive amount of biological data in genomics, proteomics, and in some other fields of biology during the gene and protein expression analysis. To extract some meaningful information and interpret the results, high throughput computational algorithms have been developed ([@B19]; [@B11]). In bioinformatics, data mining is a process of extracting useful information deep inside of large datasets ([@B40]; [@B54]; [@B30]). These techniques also involve artificial intelligence, statistics, machine learning, and visualization ([@B30]; [@B11]). Such techniques are applied to expose and analyze the hidden information inside the data or sometimes also called Intelligent Data Analysis (IDA), for better prediction of results. This knowledge discovery obtained from health data has some major objectives, including diagnosis in health sciences and simulations ([@B33]; [@B20]; [@B7]).

Traditionally implemented diagnostic methods for tuberculosis patients can be minimized with data mining approaches. National and International laboratory researchers are currently involved in developing new diagnostics, and their evaluation helps to introduce more rapid and accurate methods in the diagnosis of TB along with the evaluations of alternative algorithms for TB reference laboratories ([@B37]).

Artificial Neural Networks (ANNs) are operated by using algorithms to interpret non-linear data, independent of sequential pattern. The networks consist of a number of smaller units called neurons, organized between the input of data and the output of results into many layers. The ANN perform and behave like biological neurons, and this behavior may be learned through a backpropagation process. In this process, the precise output of a data set is previously known as input into the network. The least mean square difference of the entire data set is minimized by the continuous comparison of output of the ANN to the known output. A good level precision is adjusted by performing complex tasks without many computing resources ([@B14]).

The main advantage usually provided by ANN is their capability to extract hidden linear and non-linear relationships, even in the high dimensional and complex data sets ([@B53]). In order to ease clinical decision makers, some more rapid evaluation techniques with low costs and good precision may further support in the diagnosis of TB to give optimum time for therapy, especially in TB high burden countries. Modern methods in data mining along with some traditional methods like regression have proven to be useful for comparison of prediction power of different models. The objective behind the current study is to support physicians in diagnosis, using predictive models as a diagnostic method for TB. Here, this investigation presents the data mining methods, i.e., classification, decision tree algorithm on the TB suspect data sets with selected attributes of patients to predict the presence or absence of TB disease. This information can be applied to develop less expensive diagnostic methods, dropping drug effects, data modeling, management of health care information systems, public health, and also patient's future prediction.

Materials and Methods {#s1}
=====================

Ethics Statement
----------------

This study proposal was approved and permitted by Institutional Committee (Ref 30/CUST2017) and incharge and molecular biologist, Provincial Tuberculosis Research Lab (PTRL) (Ref No. 1-06-17) where individual patient names and sensitive information were removed and neither of the these have been linked with an individual TB suspect. Further, the study was also conducted according to the WHO Standards and Operational Guidance for Ethics Review of [@B50]. Annex-3(IV)-B (13).

Data Mining of TB Patient Data
------------------------------

Data in the current research was retrieved from TB control program at PTRL, Hayatabad Medical Complex Peshawar. All follow up and diagnostic patients have been included and the data of patients has been collected from guardians or care takers. The data include location, age, gender, sample type, history, HIV status. The data set contain information's from 36 different TB units of Khyber Pakhtunkhwa (KPK). The characteristics of data is given [Table 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}.

###### 

Characteristics of TB suspects/patients received from KPK TB units.

  Characteristics    No.     Characteristics   No.     Characteristics     No.
  ------------------ ------- ----------------- ------- ------------------- -------
  **Gender**                 **Hiv status**            **Sample type**     
  Female             6445    Hiv +ve           534     Sputum              11089
  Male               6043    Hiv −ve           5       Pleural fluid       343
  ^∗^Other           148     Unknown           12097   ^∗^BAL              312
  Total              12636   Total             12636   Gastric aspirate    224
                                                       ^∗^CSF              172
  **History**                **Age group**             Pus                 124
  Diagnosis          10416   0.1--14           1072    Ascetic fluid       117
  Follow up          2220    15--24            3474    Tissue              104
  Total              12636   25--34            2438    Urine               69
                             35--44            1678    Pericardial fluid   43
  **Disease type**           45--54            1690    Synovial fluid      16
  Extra pulmonary    1323    55--64            1336    Lymph node          11
  Pulmonary          11313   65--74            661     Total               12636
  Total              12636   75--84            222     **Culture**         
                             85--94            55      MTB                 1809
                             95--104           8       No growth           10827
                             100--105          2       Total               12636
                             Total             12636                       

∗

CSF, cerebrospinal fluid; BAL, bronchoalveolar lavage; Other, she male.

###### 

Number of TB suspects received from different units of KPK province.

  S.No.   Health center           Cases   S.No.   Health center                 Cases
  ------- ----------------------- ------- ------- ----------------------------- -------
  1       ^∗^ATO Khyber agency    71      20      DTO Sawabi                    32
  2       ^∗^CMH                  296     21      DTO Shangla                   4
  3       ^∗^DTO Bajawar agency   11      22      DTO Swat                      6
  4       DTO Bannu               8       23      Hayatabad medical complex     1903
  5       DTO Buner               8       24      Khyber teaching hospital      699
  6       DTO Charsadda           54      25      Kuwait hospital               21
  7       DTO Chitral             5       26      Leady reading hospital        2
  8       DTO D.I. Khan           8       27      Mardan medical complex        8
  9       DTO Dir Lower           7       28      ^∗^PMDT ATH                   627
  10      DTO Dir Upper           13      29      PMDT leady reading hospital   5333
  11      DTO Hangu               39      30      PMDT ^∗^MMTH                  1255
  12      DTO Kohat               8       31      PMDT Swat                     855
  13      DTO Kohistan            1       32      Private                       2
  14      DTO Lakki               2       33      Peshawar reference lab        111
  15      DTO Malakand            4       34      Rehman medical institute      66
  16      DTO Mansehra            1       35      DTO Takht Nusrati             4
  17      DTO Mardan              17      36      TB control Ganj               1
  18      DTO Noshera             37                                            
  19      DTO Peshawar            1117            Total                         12636

∗

ATH, Ayub Teaching Hospital; ATO, Agency TB officers; CMH, Combined Military Hospital; DTO, district TB control officers; MMTH, Mufti Mehmood Teaching Hospital; PMDT, Programmatic Management of Drug Resistant TB.

Dataset Development
-------------------

Suspects referred by TB units and health care centers during the years 2016 and 2017, were included. Samples were processed and cultured according the previous study ([@B25]; [@B26]) and MTB negative and positive was confirmed after the culture result. Further confirmation was carried, using BD MGIT MTBc identification test (TBc ID, Ref: 245159, Becton, Dickinson), a rapid chromatographic immunoassay which detects the MTB complex antigen MPT64 secreted during culture ([@B3]). The dataset was validated by MATLAB software ([@B5]). Total 12,636 inputs were used in order achieve a good output efficiency, where 70% were used as a training dataset and the remaining 30% were used as testing ([@B14]; [@B29]). The validation observed for test dataset was about 93.71%.

Artificial Neural Networks Approach
-----------------------------------

Artificial neural networks are nature inspired algorithms ([@B19]) that include input layer node, hidden layer node, and output node. Every node in a layer has one parallel node in the layer following it, thereby consequently building the stacking. Back-propagation learning algorithm is based on gradient descent search algorithms to fiddle with the correlation weight ([@B45]; [@B24]). The output of every neuron was the aggregation of information of neurons of the prior stage multiplied by parallel weights with biased value. Input value was transformed into output with respect to activated functions shown in [Figure 1](#F1){ref-type="fig"}.

![Neural network structure of MTB dataset where dataset was categorized into three categories input, hidden, and output layers. "W" represent weight parameter with layer node, "B" represent bias unit.](fmicb-10-00395-g001){#F1}

**Step 1** -- Normalization of MTB Dataset.

TB patients dataset was normalized according to proposed study ([@B24]).

V

new

=

(

V

old

−

MinV

)

/

(

MaxV

−

MinV

)

∗

(

D

max

−

D

min

)

\+

D

min

where V~new~ represent new assessment post-normalization, V~old~ is the assessment before normalization, MinV is the variable's minimum assessment, MaxV is the variable's maximum estimation. Dmax and Dmin are the maximum estimation succeeding normalization and the minimum assessment subsequent to normalization, respectively.

**Step 2** -- Input the data for training, the interrelated values of input and output execute for training using feed forward back propagation neural network algorithms.

**Step 3** -- Set Network constraint.

**Step 4** -- Calculate the neurons of output, every neuron output signal calculated using
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where netj and w~ji~ are output neurons and connection weight neurons, respectively, while xi and bj are the input signal, and bias neurons. The sigmoid function or logistic function, also called the sigmoidal curve ([@B41]), was used for netj and every neuron of ten hidden layers.

**Step 5** -- Signal of output layers' calculation using,
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where TV~k~ is target value of output neurons and $\text{δ}_{\text{K}}^{\text{L}}$ is the error of neuron.

**Step 6** -- Compute the error of neuron k and step 3 and step 6 were repetitive until network was congregated, and the error was computed using,
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where T~i~ is actual assessment and Y~i~ is estimated assessment.

A step by step flowchart methodology has been given in [Figure 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}.

![Flow chart of ANN methodology for data processing, normalization, training, testing, and prediction.](fmicb-10-00395-g002){#F2}

Results
=======

The drug resistance and patient's characteristics has been shown in [Figure 4](#F4){ref-type="fig"}. MDR are very high among the population of KPK followed by other first line drug resistance. Although XDR are very few, they are very hard to treat and often take years to recover and the chances are very rare. Mono-resistant (resistant to any single drug) and poly resistant (resistant to any two or more drugs other than MDR and XDR) have been found in significant numbers. This high prevalence of drug resistance may be due to the delay type of diagnosis of some gold standard methods like culture. Owing to the current situation, we applied ANN on the patient records to find the accuracy of prediction.

Based on the ANN, the data used in the current study has 12,636 records ([Table 1](#T1){ref-type="table"}), where 70 and 30% were used as training and test sets, respectively. The accuracies of test and validation to predict TB based on patient data, were found at 93.90 and 93.71%, respectively. ANN-based, this algorithm accurately predicted that a suspect may have TB or not and generated the output through the hidden layer implementation. The hidden layers, learning parameters of ANN were as follows.

  ----------------------------------------- -----------
  **Number of input layer units**           **12636**
  **Number of hidden layers**               10
  **Number of first hidden layer units**    10
  **Number of second hidden layer units**   10
  **Number of output layer units**          1
  **Momentum rate**                         0.88
  **Learning rate**                         0.70
  **Error after learning**                  0.000050
  **Learning cycle**                        30,000
  ----------------------------------------- -----------

The Architecture of ANN
-----------------------

1.  Initialize the weight and parameters μ (μ = 0.01)

2.  Compute the sum of the squared errors overall input F(w) = e^T^e

    Where weight of network w = \[w1, w2, w3.... w~n~\] and e is the error vector for the network.

3.  Solve to obtain the increment of weight Δw = \[J^T^ J + μI\]^−1^ J^T^ e

    Where J is jacobian matrix, μ is learning rate neither μ is multiplied by decay rate β(0 \< β \< 1).

4.  Using w+ Δw

    F(w) \< F(w) then (go back to Step 2)

    W = w+ Δw

    μ = μ.β (β = 0.1) (go back to Step 2)

    ELSE

    μ = μ/β (go back to Step 2)

    END IF

The approach has been found efficient and possesses robust application for TB disease prediction with prediction accuracy. Using this approach, users can predict the active TB positively or negatively based on the patient's data after clinical sign symptoms including, cough that lasts 3 weeks or longer and pain in the chest coughing up blood or sputum (mucus from deep inside the lungs). Other symptoms of TB disease may include; weakness or fatigue, weight loss, no appetite, chills, fever, sweating at night ([@B6]).

User input data include; age, gender (male, female, other), sample type \[bone, bone marrow, bronchoalveolar lavage, cerebrospinal fluid (CSF), gastric aspirate, lung biopsy, lymph nodes, pericardial fluid, pleural fluid, synovial fluid, pus, tissue biopsy, urine, sputum\], history (follow up, diagnostic), HIV status (positive, negative, unknown). The model includes 70% training and 30% test set of the entire data set (12636 records) where the validation score was achieved with an accuracy of 94%.

The approach was written in MATLAB script where prediction accuracy was achieved as \>94% based on ANN ([Figure 3](#F3){ref-type="fig"}), dependent on dataset, where dataset input and hidden layer were categorized on two basic parameters W (weight) and B (bias unit), which contain ten sub-models and generate single output based on dataset accuracy. Users can predict their TB risk after entering their data, history, and the appearance of signs and symptoms.

![Depicts artificial neural network prediction on the basis of normalized data of MTB. Out of 12636 records, 70% was training and 30% was test set where the validation score was achieved with an accuracy of about 94%. The overall model got an accuracy of 94.58%.](fmicb-10-00395-g003){#F3}

Discussion
==========

Tuberculosis is a challenging disease; in spite of advanced technologies, the diagnosis is often difficult because of the nature of the disease ([@B12]; [@B47]; [@B49]). Clinical diagnosis requires standardization, where immunodiagnostic tests may help to improve sensitivity, but not in latent TB and some lack specificity ([@B34]; [@B17]). Xpert MTB/RIF have been saving our time to detect MTB, but decades old technologies like culture still remained the standard. Today, the battle against TB still poses one of the primary diagnostic problems in the pediatric laboratory ([@B15]). Delay in notification and a weak coordination among TB management might be a cause to unnecessary diagnosis and treatment initiation ([@B51]; [@B23]). Although the Xpert MTB/RIF assay offers fast diagnostic facility within 2 h, in some sample types like lymph node tissue biopsy (extrapulmonary TB) the overall sensitivity to rule out the TB is suboptimal ([@B9]; [@B36]; [@B46]). Performance was found to vary according to specimen type and acid-fast bacilli smear status. Further, the gold standard for MTB drug susceptibility testing is still culture on solid media, taking weeks to months to grow ([@B31]; [@B13]; [@B27]). Treatment is often empirical and initiated after looking at factors like past medical or social history, or the prevalence of drug resistance in that locality. These may delay the initiation of proper TB treatment that lead to drug resistance ([@B39]; [@B32]; [@B13]; [@B26]). The high prevalence of drug resistance in TB high burden countries may delay the initiation of appropriate treatment due to culture of MTB *in vitro* which is a time consuming method. These issues should be addressed through more studies especially in TB high burden regions. We found an increased drug resistance in the recent years' data ([Figure 4](#F4){ref-type="fig"}) calculation, pointing toward advanced computational technologies to integrate for diagnosis in MTB prediction ([@B26]).

![**(A)** Drug resistance among MTB isolates from Khyber Pakhtunkhwa. Frequency of all sensitive, MDR, Mono_Resistant, Poly resistant, and XDR are color coded. **(B)** Patients data and drug resistance pattern. Drug resistance is shown by red color while drug sensitive isolates are colored yellow. Resistance type (Resist_Type), Sample_Type, TB_Type, previous TB History of patients, and Gender are color coded.](fmicb-10-00395-g004){#F4}

Modern neural networks have attained a great significance and importance in the recognition of images ([@B14]; [@B28]; [@B18]; [@B24]), speech recognition ([@B22]), and processing of natural language ([@B43]). Medicinal researchers have started to apply these tactics in personalized clinical care. Diabetic retinopathy has also been identified through the approaches of deep neural networks ([@B21]) and classifying cancers of skin ([@B18]). The applications of such approaches have also been found to be successful in computational biology and bioinformatics such as in inferring target gene expression ([@B8]), predicting RNA-binding protein sites ([@B52]), and in identification and prediction of biomarkers for human chronological age ([@B38]). To reduce cost and time wastage, various data mining approaches may be helpful in diagnosis and on time initiation of TB therapy.

According to the WHO global TB report, 2018, India, Indonesia, China, Philippines, and Pakistan are the top five countries with 56% TB prevalence of the world. Timely TB diagnosis to reduce transmission and initiation of treatment to improve the outcomes for TB patients is essential, especially in high burden countries ([@B51]; [@B12]).

Classification and clustering algorithms are working efficiently with good precision in the prediction of the tuberculosis diagnosis. Presence of MTB and patient's data may support such model up to large extents. When handling high-dimensional classification problems, different modeling approaches may be used. Earlier works have applied multivariate logistic regression ([@B48]; [@B44]), classification trees ([@B33]; [@B2]) and ANN ([@B1]; [@B11]) for predicting smear-negative TB.

Conclusion
==========

Artificial neural networks may be applied as a diagnostic tool for TB prediction and supportive in expanding the role for computer technologies in diagnostics for a rapid management of TB. Therefore, this high correlation (\>94% accuracy) with the experimental result of MTB detection may help to choose optimal therapeutic regimens, especially in TB high burden countries. Delays in TB diagnosis and initiation of treatment may allow the emergence of new cases by transmission, and is one of the causes of high drug resistance in TB high burden countries.

The approach developed here may offer and support the rapid diagnosis of MTB with further additions such as drug resistance prediction in near future for better TB management.
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